Navigation Links
Thomson Acquires Prous Science
Date:9/26/2007

Acquisition to Expand Thomson Scientific's Market-leading Portfolio of

Chemistry and Drug Discovery Information Solutions

STAMFORD, Conn., Sept. 27 /PRNewswire-FirstCall/ -- The Thomson Corporation (NYSE: TOC; TSX: TOC), a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific. Financial terms of the transaction were not disclosed.

Scientists worldwide rely on Prous Science information solutions to enhance knowledge-based drug discovery and development. Its well-known Prous Science Integrity(R) portal provides access to more than 265,000 compounds with demonstrated biological activity and close to 100,000 patent family records. Prous Science has worked closely with its customers and partners to develop this highly differentiated information offering tailored to the needs of end user scientists.

In addition, Prous Science has developed strong relationships with key global medical associations and Centers of Excellence to maximize the reach of medical knowledge to specialists worldwide.

"Prous Science has built a strong global brand on its flagship solutions which have been built by scientists for scientists," said Vin Caraher, President and CEO, Thomson Scientific. "This acquisition really complements our Pharma & Biotechnology workflow solution offerings. We look forward to working closely with the Prous Science management team to maximize synergies and add value for our customers."

"Today's announcement signals an excellent opportunity to accelerate our product d
'/>"/>

SOURCE The Thomson Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Ossur Acquires the U.S. Orthopaedics Company
2. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
3. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
4. Premier Army Hospital Acquires PET-CT Scanner
5. Wockhardt acquires Protinex, Farex brands from Netherland Co
6. Indoco Remedies Acquires La Nova Chem
7. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
8. AIIMS Acquires Four-Armed Robot to Assist in Surgeries
9. Apollos Global Arm Acquires US-based Firm
10. ‘Obesity’ Acquires Permanent Resident Status in the US
11. Indias Wockhardt Acquires Irish Firm
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Las Colinas FREE Community Health Fair Benefiting the Shoh-Sohail Family of Irving 2Health News:Top Latin American Television Companies Commit to Addressing AIDS 2Health News:Top Latin American Television Companies Commit to Addressing AIDS 3Health News:Top Latin American Television Companies Commit to Addressing AIDS 4Health News:Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: JNJ, ABT, LLY, PFE, NVS, GSK 2Health News:Companion Global Healthcare Expands Service to Include Hospitals in Mexico 2Health News:LUMA Cervical Imaging System Installed in Edina at Minnesota Gynecology 2Health News:LUMA Cervical Imaging System Installed in Edina at Minnesota Gynecology 3Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 2Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 3Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 4Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 5
Breaking Medicine Technology:Al Novak Elected Chairman of the Board of OrbusNeich Medical 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 1Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 2Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 3Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 4Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 5Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 6Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 7Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 8Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 9Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 10Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 11Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 12Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 13Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 14Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 15Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 16Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 17Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 18Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 19Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 20Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 21Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 22Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 1Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 1PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 3